Biotech Penny Stocks Investing Guide
If you’re considering investing in biotech penny stocks right now, there is a lot to know. In general, we have seen a major amount of… Read More »Biotech Penny Stocks Investing Guide
If you’re considering investing in biotech penny stocks right now, there is a lot to know. In general, we have seen a major amount of… Read More »Biotech Penny Stocks Investing Guide
The clinical-stage biopharmaceutical company discussed in today’s article, which is focused on developing innovative cancer therapies.
“It was a difficult first half for biotech stocks, once again underscoring how conditions may seem so ideal but investment returns can still be hard to generate.”
If you feel like biotech stocks tend to go down right after you buy them, you’re not alone – and today’s article provides some important insights into what’s going on.
Information collected through genetic testing business has the potential to become a powerful drug developer.
Examining four oncology stocks that could be smart picks right now.
After trailing the broader market for the past few months, biotech has gotten some love in recent days – from the FDA in the form of its approval of Biogen’s controversial Alzheimer’s drug, and also from the Reddit crowd.
As PDUFA dates can serve as catalysts for stocks, biotech investors can be well served by paying attention to them.
The biotech featured in today’s article “selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a significant benefit over existing products.”
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s… Read More »5 Stocks Under $10 With Big Upside Potential – Including 2 Microcap Biotech Stocks